Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

SHE:002252 Revenue

Shanghai RAAS Blood Products had revenue of 1.70B CNY in the quarter ending June 30, 2026, a decrease of -12.66%. This brings the company's total for the last twelve months to 6.61B, down -16.13% year-over-year. In the year 2025, Shanghai RAAS Blood Products had annual revenue of 7.35B, down -10.13%. That makes Shanghai RAAS Blood Products the 7,657th largest company in the world by revenue and 1,110th in China.

• Revenue (ttm): 6.61B
• Revenue Growth: -16.13%
• P/S Ratio: 4.77
• Revenue / Employee: 1.63M
• Employees: 4,045
• Market Cap: 31.38B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 2.60B 35.4%
• Northern China 2.09B 28.5%
• Southern China 1.55B 21.0%
• Southwest Region 488.64M 6.6%
• Northwestern Region 304.93M 4.1%
• Northeast China Region 264.70M 3.6%
• Export 52.44M 0.7%

Fiscal year ended Dec 31, 2025 See the full SHE:002252 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.35B	-828.28M	-10.13%
Dec 31, 2024	8.18B	212.50M	2.67%
Dec 31, 2023	7.96B	1.40B	21.27%
Dec 31, 2022	6.57B	2.28B	53.16%
Dec 31, 2021	4.29B	1.53B	55.26%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error